-
PDF • September 2023Observation letters from BSE and NSE for the Scheme of DemergerPDF • September 2023Change in Sr. ManagementPDF • August 2023Reg 30 – Pending LitigationPDF • August 2023Change in Sr. ManagementPDF • June 2023Resignation of DirectorVideo • May 2023Recording of Investor / Analyst Call - May 2023PDF • May 2023Presentation of Investor/Analyst call May 2023PDF • May 2023Reg 30 Scheme of arrangementPDF • May 2023Intimation for Investor / Analysts Call – May 2023PDF • April 2023Announcement Under Regulation 30 - NLEM CommunicationPDF • Feb 2023Investor / Analyst Meet Transcript 24.02.2023PDF • 2023-02-24Presentation for Investor / Analyst call – Feb 2023PDF • 2023-02-16Intimation for Investor / Analysts Call
-
PDF • 2022-03-11Announcement under Regulation 30 (LODR)-Change in DirectoratePDF • 2022-09-16Reg 30 anouncement - NSE BSE NLEM
-
PDF • November 26, 2021Divestment of Soframycin® and Sofradex® businessesPDF • November 24, 2021Resignation of Non-Executive DirectorPDF • October 27, 2021Appointment of Company Secretary and change in Compliance OfficerPDF • August 13, 2021Resignation of Company Secretary (Key Managerial Personnel) & Change in Compliance OfficerPDF • July 28, 2021Slump Sale and transfer of the Nutraceuticals business of the CompanyPDF • March 17, 2021Investor Webinar Presentation - 17th March 2021PDF • February 24, 2021Intimation for Investor Webinar on 17th March 2021PDF • February 24, 2021Appointment / Re-appointment of Directors, Re-appointment of Chairman
-
PDF • October 06, 2020Authorized officials for disclosure of material information to Stock ExchangesPDF • October 05, 2020Appointment of Chief Financial OfficerPDF • September 16, 2020Resignation of Whole Time Director & Chief Financial OfficerPDF • July 28, 2020Disclosure on Impact of COVID-19
-
PDF • September 11, 2019Outcome of Board Meeting held on 10th September 2019PDF • May 7, 2019Resignation of Whole Time DirectorPDF • February 19, 2019Clarification on the media report in ‘The Hindu’
-
PDF • November 13, 2018Clarification on the media report in the Indian ExpressPDF • May 09, 2018Change in Chief Financial Officer
-
PDF • 2016-01-12Disclosure under Regulation 30(5) of LODR 2015 - 10.12.2015
Disclosures under Reg. 30 of the Listing Regulations 2023
Disclosures under Reg. 30 of the Listing Regulations 2022
Disclosures under Reg. 30 of the Listing Regulations 2021
Disclosures under Reg. 30 of the Listing Regulations 2020
Disclosures under Reg. 30 of the Listing Regulations 2019
Disclosures under Reg. 30 of the Listing Regulations 2018
Disclosures under Reg. 30 of the Listing Regulations 2015
You are about to leave sanofiindialtd.com website
By clicking on Proceed, you will be redirected to External Website.
Do you wish to Proceed ?